By Michele Maatouk
Date: Tuesday 06 Jan 2026
(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.
| SEP cashes in as US giant Amgen buys cancer drug... | 26-Jan-2011 | The Scotsman |
| Amgen Buys a Cancer Drug Maker | 25-Jan-2011 | New York Times |
| Tech Ticker | 16-Dec-2010 | BayArea.com |
| Amgen drug delayed spread of prostate cancer to ... | 15-Dec-2010 | LA Times |
| Business Briefing | 24-Dec-2009 | LA Times |
| Currency | US Dollars |
| Share Price | $ 343.92 |
| Change Today | $ 2.04 |
| % Change | 0.60 % |
| 52 Week High | $351.32 |
| 52 Week Low | $262.28 |
| Volume | 1,040,202 |
| Shares Issued | 536.90m |
| Market Cap | $184,651m |
| RiskGrade | 100 |
| Strong Buy | 7 |
| Buy | 8 |
| Neutral | 14 |
| Sell | 2 |
| Strong Sell | 1 |
| Total | 32 |

| Time | Volume / Share Price |
| 14:55 | 200 @ $343.92 |
| 14:55 | 40 @ $343.92 |
| 14:55 | 40 @ $343.96 |
| 14:55 | 40 @ $343.96 |
| 14:54 | 50 @ $343.92 |
You are here: research